4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-14-022851
Options or other derivatives
- Vice President & Secretary acquired 50,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
SEGALL JUDITH · Vice President & Secretary
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-03-20 | Other acquisition : show line 1 in the form Option to Purchase Common Shares | +50,000 | $3.51 | 2021-03-19 | 50,000 | 50,000 | D |
Loading xslF345X03/doc4.xml…